Tech Company Financing Transactions
PharmaCCX Funding Round
PharmaCCX secured a $3 million Seed venture capital round on 11/21/2018. Investors included Accel Partners, Atlantic Labs and Green D Ventures.
Transaction Overview
Company Name
Announced On
11/21/2018
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
The company will use the funds to continue developing its proprietary technology platform and initiate deployments in several European countries.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
200 Portland St.
Boston, MA 02114
USA
Boston, MA 02114
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
PharmaCCX has taken principles from Finance and is applying them to Pharma negotiations. Focused primarily on European single payer markets and combination oncology products, PharmaCCX is working with Payers and Pharma to deliver on a new method and platform to expedite complicated negotiations that were previously not possible or very difficult to complete.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nathan Sigworth
Chief Operating Officer
Peter Rice
Co-Founder
Richard Bergstrom
Browse more venture capital transactions:
Prev: 11/21/2018: ExO Foundation venture capital transaction
Next: 11/21/2018: Dispatch Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs